Cargando…
Genetic and Metabolite Variability in One-Carbon Metabolism Applied to an Insulin Resistance Model in Patients With Schizophrenia Receiving Atypical Antipsychotics
Background: Patients with schizophrenia are at high risk of pre-mature mortality due to cardiovascular disease (CVD). Our group has completed studies in pharmacogenomics and metabolomics that have independently identified perturbations in one-carbon metabolism as associated with risk factors for CVD...
Autores principales: | Ward, Kristen M., Burghardt, Kyle, Kraal, A. Zarina, Jaeger, Andrew, Yeomans, Larisa, McHugh, Cora, Karnovsky, Alla, Stringer, Kathleen A., Ellingrod, Vicki L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185170/ https://www.ncbi.nlm.nih.gov/pubmed/34113268 http://dx.doi.org/10.3389/fpsyt.2021.623143 |
Ejemplares similares
-
Fatty Acid Desaturase Gene Polymorphisms and Metabolic Measures in Schizophrenia and Bipolar Patients Taking Antipsychotics
por: Burghardt, Kyle J., et al.
Publicado: (2013) -
Depressive Symptoms Longitudinally Mediate the Negative Effects of HbA1c on Memory Change Over 6 Years
por: Kraal, A Zarina, et al.
Publicado: (2020) -
Atypical Antipsychotics and the Human Skeletal Muscle Lipidome
por: Burghardt, Kyle J., et al.
Publicado: (2018) -
Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia
por: Kumar, Pooja, et al.
Publicado: (2021) -
Severity in schizophrenia patients receiving atypical antipsychotic medications
por: Alam Fatmi1j, Syed Meraj, et al.
Publicado: (2022)